Selected research
Market Structure
Global Metformin Hydrochloride Preparation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Metformin Hydrochloride Preparation market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Metformin Hydrochloride Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Metformin Hydrochloride Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Metformin Hydrochloride Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Metformin Hydrochloride Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Metformin Hydrochloride Preparation include Yiling Pharmaceutical, Topfond Pharmaceutical, Teva Pharmaceuticals, CSPC, Sandoz, Sanofi, Nanjing Yewin, Merck and Jiangsu Deyuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Metformin Hydrochloride Preparation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Metformin Hydrochloride Preparation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Metformin Hydrochloride Preparation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metformin Hydrochloride Preparation market size, projected growth trends, production technologies, key applications, and end-use industries.
Metformin Hydrochloride Preparation Segment by Company
Yiling Pharmaceutical
Topfond Pharmaceutical
Teva Pharmaceuticals
CSPC
Sandoz
Sanofi
Nanjing Yewin
Merck
Jiangsu Deyuan Pharmaceutical
Sinocorp Pharma
Jingfeng Pharmaceutical Group
Bayer
Bristol Myers Squibb
Viatris
Sun Pharmaceutical Industries
Dr. Reddy's Laboratories
Apotex
Metformin Hydrochloride Preparation Segment by Type
Sustained Release Dosage
Regular Release Dosage
Metformin Hydrochloride Preparation Segment by Application
Hospital
Clinic
Other
Metformin Hydrochloride Preparation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Hydrochloride Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metformin Hydrochloride Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Hydrochloride Preparation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Metformin Hydrochloride Preparation market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metformin Hydrochloride Preparation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metformin Hydrochloride Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Metformin Hydrochloride Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Sustained Release Dosage
- Regular Release Dosage
Applications
- Hospital
- Clinic
- Other
Companies covered
- Yiling Pharmaceutical
- Topfond Pharmaceutical
- Teva Pharmaceuticals
- CSPC
- Sandoz
- Sanofi
- Nanjing Yewin
- Merck
- Jiangsu Deyuan Pharmaceutical
- Sinocorp Pharma
- Jingfeng Pharmaceutical Group
- Bayer
- Bristol Myers Squibb
- Viatris
- Sun Pharmaceutical Industries
- Dr. Reddy's Laboratories
- Apotex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Metformin Hydrochloride Preparation Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Metformin Hydrochloride Preparation Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Metformin Hydrochloride Preparation Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Metformin Hydrochloride Preparation Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Metformin Hydrochloride Preparation Market Dynamics
- 2.1 Metformin Hydrochloride Preparation Industry Trends
- 2.2 Metformin Hydrochloride Preparation Industry Drivers
- 2.3 Metformin Hydrochloride Preparation Industry Opportunities and Challenges
- 2.4 Metformin Hydrochloride Preparation Industry Restraints
3 Metformin Hydrochloride Preparation Market by Manufacturers
- 3.1 Global Metformin Hydrochloride Preparation Revenue by Manufacturers (2021-2026)
- 3.2 Global Metformin Hydrochloride Preparation Sales by Manufacturers (2021-2026)
- 3.3 Global Metformin Hydrochloride Preparation Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Metformin Hydrochloride Preparation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metformin Hydrochloride Preparation Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Metformin Hydrochloride Preparation Manufacturers, Product Type & Application
- 3.7 Global Metformin Hydrochloride Preparation Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Metformin Hydrochloride Preparation Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Metformin Hydrochloride Preparation Players Market Share by Revenue in 2025
- 3.8.3 2025 Metformin Hydrochloride Preparation Tier 1, Tier 2, and Tier 3
4 Metformin Hydrochloride Preparation Market by Type
- 4.1 Metformin Hydrochloride Preparation Type Introduction
- 4.1.1 Sustained Release Dosage
- 4.1.2 Regular Release Dosage
- 4.2 Global Metformin Hydrochloride Preparation Sales by Type
- 4.2.1 Global Metformin Hydrochloride Preparation Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Metformin Hydrochloride Preparation Sales by Type (2021-2032)
- 4.2.3 Global Metformin Hydrochloride Preparation Sales Market Share by Type (2021-2032)
- 4.3 Global Metformin Hydrochloride Preparation Revenue by Type
- 4.3.1 Global Metformin Hydrochloride Preparation Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Metformin Hydrochloride Preparation Revenue by Type (2021-2032)
- 4.3.3 Global Metformin Hydrochloride Preparation Revenue Market Share by Type (2021-2032)
5 Metformin Hydrochloride Preparation Market by Application
- 5.1 Metformin Hydrochloride Preparation Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Metformin Hydrochloride Preparation Sales by Application
- 5.2.1 Global Metformin Hydrochloride Preparation Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Metformin Hydrochloride Preparation Sales by Application (2021-2032)
- 5.2.3 Global Metformin Hydrochloride Preparation Sales Market Share by Application (2021-2032)
- 5.3 Global Metformin Hydrochloride Preparation Revenue by Application
- 5.3.1 Global Metformin Hydrochloride Preparation Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Metformin Hydrochloride Preparation Revenue by Application (2021-2032)
- 5.3.3 Global Metformin Hydrochloride Preparation Revenue Market Share by Application (2021-2032)
6 Global Metformin Hydrochloride Preparation Sales by Region
- 6.1 Global Metformin Hydrochloride Preparation Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Metformin Hydrochloride Preparation Sales by Region (2021-2032)
- 6.2.1 Global Metformin Hydrochloride Preparation Sales by Region (2021-2026)
- 6.2.2 Global Metformin Hydrochloride Preparation Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Metformin Hydrochloride Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Metformin Hydrochloride Preparation Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Metformin Hydrochloride Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Metformin Hydrochloride Preparation Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Metformin Hydrochloride Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Metformin Hydrochloride Preparation Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Metformin Hydrochloride Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Metformin Hydrochloride Preparation Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Metformin Hydrochloride Preparation Revenue by Region
- 7.1 Global Metformin Hydrochloride Preparation Revenue by Region
- 7.1.1 Global Metformin Hydrochloride Preparation Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Metformin Hydrochloride Preparation Revenue by Region (2021-2026)
- 7.1.3 Global Metformin Hydrochloride Preparation Revenue by Region (2027-2032)
- 7.1.4 Global Metformin Hydrochloride Preparation Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Metformin Hydrochloride Preparation Revenue (2021-2032)
- 7.2.2 North America Metformin Hydrochloride Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Metformin Hydrochloride Preparation Revenue (2021-2032)
- 7.3.2 Europe Metformin Hydrochloride Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Metformin Hydrochloride Preparation Revenue (2021-2032)
- 7.4.2 Asia-Pacific Metformin Hydrochloride Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Metformin Hydrochloride Preparation Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Metformin Hydrochloride Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yiling Pharmaceutical
- 8.1.1 Yiling Pharmaceutical Company Information
- 8.1.2 Yiling Pharmaceutical Business Overview
- 8.1.3 Yiling Pharmaceutical Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yiling Pharmaceutical Metformin Hydrochloride Preparation Product Portfolio
- 8.1.5 Yiling Pharmaceutical Recent Developments
- 8.2 Topfond Pharmaceutical
- 8.2.1 Topfond Pharmaceutical Company Information
- 8.2.2 Topfond Pharmaceutical Business Overview
- 8.2.3 Topfond Pharmaceutical Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Topfond Pharmaceutical Metformin Hydrochloride Preparation Product Portfolio
- 8.2.5 Topfond Pharmaceutical Recent Developments
- 8.3 Teva Pharmaceuticals
- 8.3.1 Teva Pharmaceuticals Company Information
- 8.3.2 Teva Pharmaceuticals Business Overview
- 8.3.3 Teva Pharmaceuticals Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Teva Pharmaceuticals Metformin Hydrochloride Preparation Product Portfolio
- 8.3.5 Teva Pharmaceuticals Recent Developments
- 8.4 CSPC
- 8.4.1 CSPC Company Information
- 8.4.2 CSPC Business Overview
- 8.4.3 CSPC Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 CSPC Metformin Hydrochloride Preparation Product Portfolio
- 8.4.5 CSPC Recent Developments
- 8.5 Sandoz
- 8.5.1 Sandoz Company Information
- 8.5.2 Sandoz Business Overview
- 8.5.3 Sandoz Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sandoz Metformin Hydrochloride Preparation Product Portfolio
- 8.5.5 Sandoz Recent Developments
- 8.6 Sanofi
- 8.6.1 Sanofi Company Information
- 8.6.2 Sanofi Business Overview
- 8.6.3 Sanofi Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sanofi Metformin Hydrochloride Preparation Product Portfolio
- 8.6.5 Sanofi Recent Developments
- 8.7 Nanjing Yewin
- 8.7.1 Nanjing Yewin Company Information
- 8.7.2 Nanjing Yewin Business Overview
- 8.7.3 Nanjing Yewin Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nanjing Yewin Metformin Hydrochloride Preparation Product Portfolio
- 8.7.5 Nanjing Yewin Recent Developments
- 8.8 Merck
- 8.8.1 Merck Company Information
- 8.8.2 Merck Business Overview
- 8.8.3 Merck Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Merck Metformin Hydrochloride Preparation Product Portfolio
- 8.8.5 Merck Recent Developments
- 8.9 Jiangsu Deyuan Pharmaceutical
- 8.9.1 Jiangsu Deyuan Pharmaceutical Company Information
- 8.9.2 Jiangsu Deyuan Pharmaceutical Business Overview
- 8.9.3 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Preparation Product Portfolio
- 8.9.5 Jiangsu Deyuan Pharmaceutical Recent Developments
- 8.10 Sinocorp Pharma
- 8.10.1 Sinocorp Pharma Company Information
- 8.10.2 Sinocorp Pharma Business Overview
- 8.10.3 Sinocorp Pharma Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Sinocorp Pharma Metformin Hydrochloride Preparation Product Portfolio
- 8.10.5 Sinocorp Pharma Recent Developments
- 8.11 Jingfeng Pharmaceutical Group
- 8.11.1 Jingfeng Pharmaceutical Group Company Information
- 8.11.2 Jingfeng Pharmaceutical Group Business Overview
- 8.11.3 Jingfeng Pharmaceutical Group Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Jingfeng Pharmaceutical Group Metformin Hydrochloride Preparation Product Portfolio
- 8.11.5 Jingfeng Pharmaceutical Group Recent Developments
- 8.12 Bayer
- 8.12.1 Bayer Company Information
- 8.12.2 Bayer Business Overview
- 8.12.3 Bayer Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Bayer Metformin Hydrochloride Preparation Product Portfolio
- 8.12.5 Bayer Recent Developments
- 8.13 Bristol Myers Squibb
- 8.13.1 Bristol Myers Squibb Company Information
- 8.13.2 Bristol Myers Squibb Business Overview
- 8.13.3 Bristol Myers Squibb Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Bristol Myers Squibb Metformin Hydrochloride Preparation Product Portfolio
- 8.13.5 Bristol Myers Squibb Recent Developments
- 8.14 Viatris
- 8.14.1 Viatris Company Information
- 8.14.2 Viatris Business Overview
- 8.14.3 Viatris Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Viatris Metformin Hydrochloride Preparation Product Portfolio
- 8.14.5 Viatris Recent Developments
- 8.15 Sun Pharmaceutical Industries
- 8.15.1 Sun Pharmaceutical Industries Company Information
- 8.15.2 Sun Pharmaceutical Industries Business Overview
- 8.15.3 Sun Pharmaceutical Industries Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Sun Pharmaceutical Industries Metformin Hydrochloride Preparation Product Portfolio
- 8.15.5 Sun Pharmaceutical Industries Recent Developments
- 8.16 Dr. Reddy's Laboratories
- 8.16.1 Dr. Reddy's Laboratories Company Information
- 8.16.2 Dr. Reddy's Laboratories Business Overview
- 8.16.3 Dr. Reddy's Laboratories Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Dr. Reddy's Laboratories Metformin Hydrochloride Preparation Product Portfolio
- 8.16.5 Dr. Reddy's Laboratories Recent Developments
- 8.17 Apotex
- 8.17.1 Apotex Company Information
- 8.17.2 Apotex Business Overview
- 8.17.3 Apotex Metformin Hydrochloride Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Apotex Metformin Hydrochloride Preparation Product Portfolio
- 8.17.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Metformin Hydrochloride Preparation Value Chain Analysis
- 9.1.1 Metformin Hydrochloride Preparation Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Metformin Hydrochloride Preparation Production Mode & Process
- 9.2 Metformin Hydrochloride Preparation Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Metformin Hydrochloride Preparation Distributors
- 9.2.3 Metformin Hydrochloride Preparation Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst